ZBH (STOCKS)
Zimmer Biomet Holdings, Inc.
$95.340000
+2.220000 (+2.38%)
Prev close: $93.120000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Ivan Tornos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18,655.42M
- Employees
- 17,000
- P/E (TTM)
- 26.24
- P/B (TTM)
- 1.43
- Dividend Yield
- 103.09%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
20
Hold
3
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$2.42 | $2.42 | +0.0001 | +0.00% |
|
Sep 2025 (Q3)
|
$1.90 | $1.89 | +0.0138 | +0.73% |
|
Jun 2025 (Q2)
|
$2.07 | $2.00 | +0.0665 | +3.32% |
|
Mar 2025 (Q1)
|
$1.81 | $1.79 | +0.0223 | +1.25% |
Financial Statements
| Revenues | $8.23B |
| Benefits Costs and Expenses | $7.40B |
| Cost Of Revenue | $2.49B |
| Costs And Expenses | $7.13B |
| Gross Profit | $5.74B |
| Operating Expenses | $4.64B |
| Selling, General, and Administrative Expenses | $3.26B |
| Depreciation and Amortization | $1.09B |
| Other Operating Expenses | $288.70M |
| Operating Income/Loss | $1.10B |
| Income/Loss From Continuing Operations After Tax | $705.10M |
| Income/Loss From Continuing Operations Before Tax | $830.80M |
| Income Tax Expense/Benefit | $125.70M |
| Income Tax Expense/Benefit, Current | $212.90M |
| Income Tax Expense/Benefit, Deferred | -$87.20M |
| Interest Income/Expense After Provision For Losses | -$292.80M |
| Interest Income/Expense Operating, Net | -$292.80M |
| Net Income/Loss | $705.10M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$100.00K |
| Net Income/Loss Attributable To Parent | $705.10M |
| Net Income/Loss Available To Common Stockholders, Basic | $705.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $3.56 |
| Diluted Earnings Per Share | $3.55 |
| Basic Average Shares | 198,000,000 |
| Diluted Average Shares | 198,700,000 |
| Assets | $23.09B |
| Current Assets | $5.12B |
| Inventory | $2.29B |
| Other Current Assets | $2.83B |
| Noncurrent Assets | $17.97B |
| Fixed Assets | $2.21B |
| Intangible Assets | $4.72B |
| Other Non-current Assets | $11.05B |
| Liabilities | $10.39B |
| Current Liabilities | $2.58B |
| Accounts Payable | $303.00M |
| Wages | $477.10M |
| Other Current Liabilities | $1.80B |
| Noncurrent Liabilities | $7.80B |
| Equity | $12.71B |
| Equity Attributable To Noncontrolling Interest | $8.10M |
| Equity Attributable To Parent | $12.70B |
| Liabilities And Equity | $23.09B |
| Net Cash Flow From Operating Activities | $1.70B |
| Net Cash Flow From Operating Activities, Continuing | $1.70B |
| Net Cash Flow From Investing Activities | -$1.98B |
| Net Cash Flow From Investing Activities, Continuing | -$1.98B |
| Net Cash Flow From Financing Activities | $326.00M |
| Net Cash Flow From Financing Activities, Continuing | $326.00M |
| Net Cash Flow | $47.40M |
| Net Cash Flow, Continuing | $47.40M |
| Comprehensive Income/Loss | $762.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $762.20M |
| Other Comprehensive Income/Loss | $57.10M |
| Other Comprehensive Income/Loss Attributable To Parent | $57.10M |